Atlas Trials

Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN

Clinical trial NCT00831909 · COMPLETED

Trial details

NCT number
NCT00831909
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
NSCLC
Start date
2009-01-01
Primary completion
2010-07-01
Enrollment
3513

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.